The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...

US President Donald Trump’s recent weight loss has become the talk of the town after his recent medical exam revealed a ...

TALLMADGE, Ohio, April 24, 2025 (GLOBE NEWSWIRE) -- 2025 study stated Mitolyn is a cellular energy support supplement that ...

This brings us to Nourix, a brand-new weight-loss pill that claims to make losing weight easier and healthier. Rather than ...

Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...

Made in the USA, a new daily oral weight-loss pill from Eli Lilly won't require cold storage and is expected to hit markets ...

Lilly's announcement that it would make its experimental weight-loss pill in the U.S. comes amid administration pressure on ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its ...

Eli Lilly's stock boomed April 17 after announcing a new experimental pill that caused nearly 8% weight loss at certain ...

A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.